Lv1
30 积分 2023-07-25 加入
The efficacy and safety of fexuprazan in treating erosive esophagitis: a phase III, randomized, double‐blind, multicenter study
1天前
待确认
The efficacy and safety of keverprazan, a novel potassium‐competitive acid blocker, in treating erosive oesophagitis: a phase III, randomised, double‐blind multicentre study
1天前
已完结
Angiogenesis-related immune response may be the prelude to the syndesmophyte formation in Ankylosing spondylitis
8天前
已完结
Highly Tough and Biodegradable Poly(ethylene glycol)‐Based Bioadhesives for Large‐Scaled Liver Injury Hemostasis and Tissue Regeneration
1个月前
已完结
Safety, pharmacokinetics and pharmacodynamics of HRS‐7535, a novel oral small molecule glucagon‐like peptide‐1 receptor agonist, in healthy participants: A phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose, and food effect trial
3个月前
已完结
Cardiac Myosin Inhibition in Heart Failure With Normal and Supranormal Ejection Fraction
3个月前
已完结
Discovery of First Branched-Chain Ketoacid Dehydrogenase Kinase (BDK) Inhibitor Clinical Candidate PF-07328948
3个月前
已完结
Phase 1 Study of AAV9.LAMP2B Gene Therapy in Danon Disease
4个月前
已完结
Non‐clinical and first‐in‐human characterization of ECC5004/AZD5004, a novel once‐daily, oral small‐molecule GLP‐1 receptor agonist
4个月前
已完结
Tolerability, safety and pharmacodynamics of oral, small‐molecule glucagon‐like peptide‐1 receptor agonist danuglipron for type 2 diabetes: A 12‐week, randomized, placebo‐controlled, Phase 2 study comparing different dose‐escalation schemes
4个月前
已完结
皖公网安备34019202002308
